Truist Lifts Accenture's Price Target 46.67% to $220 on AI Growth, but Keeps a 'Hold'

Truist Raises Accenture's Target from $150 to $220, but Doesn't Change Its Rating

Truist Securities raised its price target on Accenture (ACN) from $150 to $220, a 46.67% increase, in a note published on October 2. The firm pointed to solid fiscal year-end results and the scaling of Accenture's artificial intelligence and data partnerships. However, Truist kept its Hold rating. With the stock at around $212.30, according to Investing.com, the new target leaves only about 3.6% of further upside.

The Catalyst: a Quarter That Took Apart the AI Bear Case

The revision came a day after Accenture reported results for the fourth quarter of its fiscal 2026 on October 1:

• Quarterly revenue: $18.68 billion, up 6% in U.S. dollars and 7% in local currency. That beat both the company's own guidance range ($17.75-$18.40 billion) and the LSEG consensus of $18.03 billion.
• Adjusted earnings per share: $3.29, versus the $3.18 analysts expected, up 8%.
• New bookings: $22.2 billion for the quarter, up 4% in dollars, and $84.54 billion for the full year.
• Fiscal 2026 revenue: $74.18 billion, up 6% in dollars.

The market reaction was historic. The stock rose more than 22% at one point during the session, on track for its best day ever, and closed up nearly 16%, according to CNBC. The rebound has context: before the results, Accenture shares were down about a third for the year, hit by fears that generative AI would replace part of the work done by IT consulting firms.

AI: From Threat to Growth Engine

Truist's core argument is that AI demand is broadening across Accenture's client base:

• Nearly 100 new clients started their first advanced AI work with Accenture in the quarter, bringing the fiscal-year total to more than 400.
• Bookings with its emerging AI and data partners more than tripled, and the related revenue doubled year over year.
• The company hit a record 141 client bookings of more than $100 million in the quarter.

CEO Julie Sweet said AI has been a key growth driver, highlighting partnerships in areas such as data centers and capital infrastructure. According to Sweet, the company ends the year with $85 billion in new business heading into next year.

Fiscal 2027 Outlook

Accenture's guidance came in better than the market had feared:

Metric	Fiscal 2027 outlook
Revenue growth (local currency)	3% - 6%
GAAP EPS	$14.39 - $14.81 (+6% to +9%)
EPS growth vs. fiscal 2026 adjusted EPS	+3% to +6%
Cash returned to shareholders	At least $9.5 billion

Why Truist Is Still at Hold

Raising a price target by 46.67% without changing the rating may look contradictory, but the logic is straightforward. Truist was starting from a $150 target, well below the share price, and had cut it in the preceding months, partly because of the situation in the Middle East. Moving to $220 brings the target in line with where the stock now trades. But with shares at around $212.30 after a gain of more than 20% in a week, the firm doesn't see enough upside to recommend buying.

Other firms have been more bullish since the results:

Firm	Rating	Price target
Truist Securities	Hold	$150 → $220
Stifel	Buy	$225 → $242
UBS	Buy	$275 (reiterated)
BMO	—	Raised after the results

A Lift for IT Services Stocks

Accenture's results pulled up other companies in the sector that had also been weighed down by AI fears. Cognizant rose about 8%, IBM about 3%, and the U.S.-listed shares of Wipro and Infosys gained between 6% and 7%, according to Reuters.

Sources: Investing.com, GuruFocus and TradingView for the Truist note; CNBC, Reuters (via Euronext) and Benzinga for the results, the share-price reaction and the sector move; Accenture's fiscal Q4 2026 earnings release and conference call (via Yahoo Finance and Pulse 2.0) for the figures and guidance; Investing.com for Stifel, UBS and BMO. This article does not use Alpha Vantage data: the share price comes from the press sources cited.

Key Levels and Things to Watch

1. Truist's $220 target: with the stock at around $212.30, it is very close. If shares clear it decisively, pressure on Truist to upgrade will grow
2. The range of analyst targets: from Truist's $220 to UBS's $275, showing there is no consensus on how much further the rebound can run
3. Consolidation after its best session ever: after such a sharp move, investors will watch whether the stock holds its gains or gives some back
4. Turning AI into revenue: more than 400 clients with advanced AI projects is a good sign, but the key is whether they turn into larger contracts
5. Delivering on fiscal 2027 guidance: 3% to 6% growth leaves room for disappointment if demand cools

What It Means for Investors

Accenture shows how much the market had priced in a very negative scenario for IT consulting firms: that generative AI would automate a large share of their services. Better-than-expected results, solid guidance and concrete signs of AI demand were enough to trigger the biggest one-day gain in its history.

Truist's stance is a useful reminder. A high-quality company and an attractive entry point are not the same thing. When the share price already reflects much of the good news, some analysts prefer to wait for the trend to be confirmed over the next few quarters before recommending a buy.

Conclusion

Truist raised its Accenture price target from $150 to $220 after a quarter that beat expectations and showed AI can be a growth engine for the consulting firm, not just a threat. More than 400 clients with advanced AI projects, AI and data partner bookings that more than tripled, and fiscal 2027 guidance ahead of expectations sent the stock to its best session ever. Still, by keeping its Hold rating, Truist is signaling that after a rebound of more than 20% in a week, much of that good news is already priced in. The coming quarters will show whether AI demand is strong enough to justify the market's more ambitious targets.